MX2015015589A - Composiciones y metodos para el suministro de agentes activos hidrófobos. - Google Patents
Composiciones y metodos para el suministro de agentes activos hidrófobos.Info
- Publication number
- MX2015015589A MX2015015589A MX2015015589A MX2015015589A MX2015015589A MX 2015015589 A MX2015015589 A MX 2015015589A MX 2015015589 A MX2015015589 A MX 2015015589A MX 2015015589 A MX2015015589 A MX 2015015589A MX 2015015589 A MX2015015589 A MX 2015015589A
- Authority
- MX
- Mexico
- Prior art keywords
- delivery
- hydrophobic active
- methods
- agent
- delivery composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
En la presente se describe una composición de suministro para administrar un agente activo hidrófobo. En una modalidad, se describe una composición de suministro para la administración local de un agente activo hidrófobo a un tejido u órgano de un paciente. En una modalidad, la composición de suministro incluye un agente de suministro catiónico, una cantidad terapéuticamente eficaz de un agente activo hidrófobo; y un portador acuoso farmacéuticamente aceptable. En una modalidad, el agente de suministro catiónico incluye polietilenimina (PEI). En una modalidad, la invención incluye un dispositivo de suministro de fármacos que incluye un sustrato; y partículas con el agente terapéutico recubiertas dispuestas sobre el sustrato, comprendiendo las partículas con el agente terapéutico 0recubiertas un agente terapéutico hidrófobo particulado; y un polímero de tipo vinilamina. Los métodos para elaborar la composición de suministro. Así como también kits y métodos de uso también se incluyen en la presente.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361824160P | 2013-05-16 | 2013-05-16 | |
| US14/072,520 US9555119B2 (en) | 2012-11-05 | 2013-11-05 | Composition and method for delivery of hydrophobic active agents |
| PCT/US2014/038435 WO2014186729A1 (en) | 2013-05-16 | 2014-05-16 | Compositions and methods for delivery of hydrophobic active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015015589A true MX2015015589A (es) | 2016-07-05 |
Family
ID=51898903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015015589A MX2015015589A (es) | 2013-05-16 | 2014-05-16 | Composiciones y metodos para el suministro de agentes activos hidrófobos. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2996735B1 (es) |
| JP (1) | JP6469090B2 (es) |
| CA (1) | CA2912690C (es) |
| IL (1) | IL242545B (es) |
| MX (1) | MX2015015589A (es) |
| WO (1) | WO2014186729A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105214143A (zh) | 2009-04-28 | 2016-01-06 | 苏尔莫迪克斯公司 | 用于递送生物活性剂的装置和方法 |
| US10213529B2 (en) | 2011-05-20 | 2019-02-26 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
| US9861727B2 (en) | 2011-05-20 | 2018-01-09 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
| US9757497B2 (en) | 2011-05-20 | 2017-09-12 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
| US9555119B2 (en) | 2012-11-05 | 2017-01-31 | Surmodics, Inc. | Composition and method for delivery of hydrophobic active agents |
| US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
| CA2974962C (en) * | 2015-01-29 | 2024-01-09 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
| US10478546B2 (en) | 2015-09-15 | 2019-11-19 | Surmodics, Inc. | Hemodialysis catheter sleeve |
| US20170281914A1 (en) * | 2016-03-31 | 2017-10-05 | Surmodics, Inc. | Localized treatment of tissues through transcatheter delivery of active agents |
| US10918835B2 (en) * | 2016-03-31 | 2021-02-16 | Surmodics, Inc. | Delivery system for active agent coated balloon |
| JP6929502B2 (ja) * | 2016-11-14 | 2021-09-01 | 株式会社トップ | 内視鏡用オーバーチューブ |
| US10898446B2 (en) | 2016-12-20 | 2021-01-26 | Surmodics, Inc. | Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces |
| JP7073337B2 (ja) * | 2017-03-16 | 2022-05-23 | テルモ株式会社 | バルーンカテーテルの製造方法 |
| CN118019553A (zh) * | 2021-10-05 | 2024-05-10 | 巴德血管外围设备公司 | 用于医疗设备的药物涂层 |
| CN117258050B (zh) * | 2023-11-22 | 2024-02-23 | 杭州亿科医疗科技有限公司 | 一种药物球囊及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4490421A (en) | 1983-07-05 | 1984-12-25 | E. I. Du Pont De Nemours And Company | Balloon and manufacture thereof |
| US5195969A (en) | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
| US5279607A (en) | 1991-05-30 | 1994-01-18 | The State University Of New York | Telemetry capsule and process |
| US5500180A (en) | 1992-09-30 | 1996-03-19 | C. R. Bard, Inc. | Method of making a distensible dilatation balloon using a block copolymer |
| US5414075A (en) | 1992-11-06 | 1995-05-09 | Bsi Corporation | Restrained multifunctional reagent for surface modification |
| DE4480681C2 (de) | 1994-02-17 | 2001-09-27 | Scimed Life Systems Inc | Verfahren zur Herstellung von Katheter-Ballonen und danach hergestellte orientierte Ballone |
| WO1995023619A1 (en) | 1994-03-02 | 1995-09-08 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US5714360A (en) | 1995-11-03 | 1998-02-03 | Bsi Corporation | Photoactivatable water soluble cross-linking agents containing an onium group |
| WO1997017098A1 (en) | 1995-11-08 | 1997-05-15 | Scimed Life Systems, Inc. | Method of balloon formation by cold drawing/necking |
| US6007833A (en) | 1998-03-19 | 1999-12-28 | Surmodics, Inc. | Crosslinkable macromers bearing initiator groups |
| DE19814730A1 (de) * | 1998-04-02 | 1999-10-07 | Basf Ag | Verwendung von N-Vinyllacram oder N-Vinylamin haltigen Copolymeren als Matrix zur Herstellung von festen pharmazeutischen und kosmetischen Darreichungsformen |
| US6278018B1 (en) | 1999-12-14 | 2001-08-21 | Surmodics, Inc. | Surface coating agents |
| US7797033B2 (en) | 2002-04-08 | 2010-09-14 | Smart Pill Corporation | Method of using, and determining location of, an ingestible capsule |
| US7034765B2 (en) | 2003-09-30 | 2006-04-25 | Lucent Technologies Inc. | Compact multiple-band antenna arrangement |
| US7807750B2 (en) | 2004-08-06 | 2010-10-05 | Surmodics, Inc. | Thermally-reactive polymers |
| CA2645324A1 (en) | 2006-03-15 | 2007-09-27 | Surmodics, Inc. | Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof |
| JP5591103B2 (ja) * | 2008-03-12 | 2014-09-17 | アンジェスＭｇ株式会社 | 薬剤溶出型カテーテル及びその製造方法 |
| EP2349371B1 (en) * | 2008-10-07 | 2013-12-04 | Boston Scientific Scimed, Inc. | Medical devices for delivery of therapeutic agents to body lumens |
| US20100130837A1 (en) | 2008-11-25 | 2010-05-27 | The Smart Pill Corporation | Modular ingestible capsule |
| SG10201405144VA (en) * | 2009-08-26 | 2014-10-30 | Otsuka Medical Devices Co Ltd | Medical device for placement into a lumen and manufacturing method thereof |
| US20110144373A1 (en) | 2009-12-10 | 2011-06-16 | Surmodics, Inc. | Water-soluble degradable photo-crosslinker |
| US8889760B2 (en) | 2010-03-30 | 2014-11-18 | Surmodics, Inc. | Photoactivatable crosslinker |
| US9757497B2 (en) * | 2011-05-20 | 2017-09-12 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
-
2014
- 2014-05-16 MX MX2015015589A patent/MX2015015589A/es active IP Right Grant
- 2014-05-16 JP JP2016514136A patent/JP6469090B2/ja active Active
- 2014-05-16 WO PCT/US2014/038435 patent/WO2014186729A1/en active Application Filing
- 2014-05-16 EP EP14730381.2A patent/EP2996735B1/en active Active
- 2014-05-16 CA CA2912690A patent/CA2912690C/en active Active
-
2015
- 2015-11-11 IL IL242545A patent/IL242545B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016523593A (ja) | 2016-08-12 |
| CA2912690A1 (en) | 2014-11-20 |
| CA2912690C (en) | 2022-05-03 |
| IL242545B (en) | 2020-09-30 |
| JP6469090B2 (ja) | 2019-02-13 |
| EP2996735A1 (en) | 2016-03-23 |
| WO2014186729A1 (en) | 2014-11-20 |
| EP2996735B1 (en) | 2019-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015015589A (es) | Composiciones y metodos para el suministro de agentes activos hidrófobos. | |
| MX2019003467A (es) | Formulaciones y metodos para la administracion vaginal de antiprogestinas. | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| MX2020002150A (es) | Terapia de combinación para el tratamiento del cáncer. | |
| PH12015500940A1 (en) | Bruton`s tyrosine kinase inhibitors | |
| NZ604029A (en) | Methods of treating bladder cancer | |
| PH12014501560A1 (en) | Carbamate compounds and of making and using same | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
| MX2015012760A (es) | Composicion farmaceutica que comprende un activador de ampk y un agente serotonergico y metodos de uso de la misma. | |
| WO2012027065A3 (en) | Combination therapy for treatment of disease | |
| BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
| PH12017500479A1 (en) | Liquid inhalation formulation comprising prl554 | |
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| MX2017017138A (es) | Conjugados homogeneos especificos de sitio con inhibidores de ksp. | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| CO7101247A2 (es) | Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas | |
| MX2013008175A (es) | Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos. | |
| MX2023006235A (es) | Composiciones para administracion de farmacos y metodos de uso de las mismas. | |
| MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
| MX2020005921A (es) | Formulaciones y metodos para el suministro vaginal de antiprogestinas. | |
| EA201890703A1 (ru) | Коллоидные частицы, предназначенные для применения в медицине | |
| UA109944U (uk) | Фармацевтична композиція для зниження рівня n-оксиду триметиламіну | |
| MX2018008196A (es) | Tratamiento para cancer de mama usando una combinacion de una formulacion liposomal cationica de taxano, una formulacion no liposomal de taxano y un agente activo adicional. | |
| IN2014DN10134A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |